| ¿µ¹® | fever | ÇÑ±Û | ¿ |
|---|---|---|---|
| ¼³¸í | ü¿ÂÁ¶Àý ÁßÃß°¡ ÀÌ»óÀ» ÃÊ·¡ÇØ Ã¼¿ÂÀÌ °è¼Ó »ó½ÂÇÏ¿© Áö¼ÓµÇ°í ÀÖ´Â »óŸ¦ ¸»ÇÑ´Ù. ¿øÀÎÀº ´Ù¾çÇϸç ü¿ÂÁ¶Àý ÁßÃß¿¡ Àå¾Ö(³úÁúȯ), Á¶Á÷ Àå¾Ö¿¡ ÀÇÇÑ °ÍÀÌ ÀÖ´Ù. ü¿ÂÀº ÀϹÝÀûÀ¸·Î °Üµå¶ûÀÌ, ÀÔ¾È, °ðâÀÚ¿¡¼ Àç°í, ½Ã°£Àº 10ºÐÀ» ÇÊ¿ä·Î ÇÑ´Ù. Åë»ó 37¡ÉÀÌÇÏ(°Üµå¶ûÀÌ)·Î, ÀÔ¾È ¿Âµµ´Â À̺¸´Ù 0.1~0.2¡É ³ôÀ¸¸ç, °ðâÀڿµµ´Â 0.2~0.5¡É ³ô´Ù. |
||
| ¿µ¹® | fever blister | ÇÑ±Û | ¿¼º¼öÆ÷ |
|---|---|---|---|
| ¼³¸í | 1Çü ´Ü¼ø Ç츣Æä½º ¹ÙÀÌ·¯½º(herpes simplex virus)ÀÇ °¨¿°¿¡ ÀÇÇØ¼ »ý±â´Â ÇǺκ´À¸·Î ÁÖ·ÎÀÔ¼ú¿¡ º´º¯À» °¡Áö´Â º´À» ¸»ÇÑ´Ù. ÀÔ¼úÆ÷Áø(herpes labialis)¿Í µ¿ÀǾî·Î ¾²ÀδÙ. Áï ´Ü¼øÆ÷ÁøÁß ÀÔÁÖÀ§¿¡ »ý±â´Â °ÍÀ» ÁöÁ¤ÇÏ´Â ¸»ÀÌ´Ù. ´Ü¼øÇ츣Æä½º(herpes simplex)¶õ º¸Åë ÀÛÀº ¹°ÁýÀÌ ¿©·¯ °³ ¸ð¿© »ý±â´Â ÇǺκ´À» ¸»ÇÑ´Ù. Àß ¹ß»ýÇÏ´Â °÷Àº ÀÔ¼ú, ¿ÜÀ½ºÎ µîÀ̸ç ÁÖ·Î ÇÇºÎ¿Í Á¡¸·ÀÇ ÀÌÇàºÎ¿¡ ³ªÅ¸³´Ù. ¹°ÁýÀº ½Ò¾Ë¸¸ÇÑ Å©±âÀÇ ÀÛÀº ¹°Áý ¶Ç´Â °í¸§À» Æ÷ÇÔÇÏ´Â ¹°ÁýÀ¸·Î ¸î °³°¡ ¹«¸®¸¦ Áö¾î ³ªÅ¸³ª´Âµ¥, ¸çÄ¥ Áö³ª¸é ¹°ÁýÀÇ ¸·ÀÌ ÅÍÁö°í, ÇǺÎÀÇ Ç¥¸éÀÌ Áø¹«¸£°í Çæ¾î¼ ÀÛÀº »óó¸¦ Çü¼ºÇÏ¿© ³ëÃâµÈ´Ù. ±×¸®°í µüÁö°¡ ¾É¾Æ ±»¾îÁø ´ÙÀ½ 7~10ÀÏ °¡·® Áö³ª¸é ÀúÀý·Î ³´´Â´Ù. ´Ü¼ø¼º Æ÷ÁøÀº ¹ß»ý ºÎÀ§¿¡ µû¶ó¼ ÀÔ¼úÆ÷Áø°ú À½ºÎÆ÷ÁøÀ¸·Î ±¸ºÐµÈ´Ù. ÀÔ¼úÆ÷ÁøÀº ÇÇ·ÎÇϰųª °ñÇÁÀå ¶Ç´Â ÇØ¼ö¿åÀå µîÁö¿¡¼ ÇÞºµ¿¡ ½ÉÇÏ°Ô ³ëÃâµÈ ÈÄ¿¡ À¯¹ßµÇ´Â °æ¿ì°¡ ¸¹´Ù. À½ºÎÆ÷ÁøÀº ¼º±³¿¡ ÀÇÇÏ¿© Àü¿°µÇ´Â °æ¿ìµµ ÀÖÀ¸¸ç, ÁßÁõÀÏ ´ë¿¡´Â °Ý½ÉÇÑ ¾ÆÇÄÀ» ¼ö¹ÝÇϸç ÁÖÀ§ÀÇ ¸²ÇÁÀýÀÇ Á¾´ë¸¦ ÃÊ·¡Çϱ⵵ ÇÑ´Ù. Á÷¾÷»ó Á¢ÃË ±âȸ°¡ ¸¹Àº Àǻ糪 °£È£»çÀÇ °æ¿ì´Â ¼Õ°¡¶ô ³¡¿¡ ¹ß»ýÇÒ ¶§µµ ÀÖ´Ù. À¯¾ÆÀÇ °æ¿ì¿¡´Â °í¿°ú ÀεÎÅë µîÀÇ ½ÉÇÑ Áõ¼¼°¡ ³ªÅ¸³ª±âµµ ÇÏ¿© ¶§·Î´Â ¸ñ¼û±îÁö ÀҴ´Ù. |
||
| ¿µ¹® | epidemic hemorrhagic fever | ÇÑ±Û | À¯ÇàÃâÇ÷¿ |
|---|---|---|---|
| ¼³¸í | Çѱ¹ÀüÀï´ç½Ã ±¹³»¿¡¼ ¹ß°ßµÇ¸é¼ ÇѶ§ Çѱ¹Çü ÃâÇ÷¿(Korean hemorrhagic fever)À̶ó°íµµ ºÒ¸®¿ü´ø ÀÌ º´Àº °©Àڱ⠽ÃÀÛÇÏ´Â ¿ÀÇÑ, µÎÅë, ±ÙÀ°ÅëÀ» ³ªÅ¸³»°í ÀÌ¾î¼ 3~5ÀÏ ³»¿¡ Àü½Å ÇǺΠ¹× °ø¸·ÃâÇ÷, Ç÷¼ÒÆÇ°¨¼ÒÁõ, ´Ü¹é´¢ ¹× ½ÅÀå ±â´É»ó½Ç µîÀÌ ¿Â´Ù. ¸»±â¿¡´Â ¼îÅ© ¹× Àúü¿ÂÀÌ µÉ ¼ö ÀÖ´Ù. óÀ½ 7~10ÀÏ °£¿¡ »ì¾Æ³²Àº ȯÀÚµéÀº ¼¼È÷ ȸº¹µÇ³ª ´Ü¹é´¢ÀÇ ÇÌ´¢´Â ¼ö ÁÖ°£ Áö¼ÓµÈ´Ù. Áõ¼¼¿¡ µû¶ó¼ ¹ß¿±â, ÀúÇ÷¾Ð±â, °¨´¢±â, ÀÌ´¢±â, ȸº¹±â·Î ºñ±³Àû ƯÀÌÇÏ°Ô ±¸ºÐµÈ´Ù. Hantaan virus¶ó°í ºÒ¸®´Â ÀÌ º´¿øÃ¼´Â ¼¼Æ÷Áú¿¡¼ ÀÚ¶ó´Â RNA ¹ÙÀÌ·¯½ºÀ̸ç Bunyaviridae°ú¿¡ ¼ÓÇÏ´Â Hanta ¹ÙÀÌ·¯½º¼Ó¿¡ ¼ÓÇÏ´Â Á¾(species)À¸·Î ÇÑź ¹ÙÀÌ·¯½º À̿ܿ¡ Puumula virus, Hill virus°¡ ÀÖ´Ù. ÃÖ±Ù¿¡ ȯÀڷκÎÅÍ ÇÑź¹ÙÀÌ·¯½º¿Í´Â ±¸ºÐµÇ´Â Seoul virus°¡ ºÐ¸®, µ¿Á¤µÊ¿¡ µû¶ó¼ ¾ß¿ÜÇü(Hantaan virus)°ú µµ½ÃÇü(Seoul virus)ÀÌ º´¿øÃ¼°¡ ¼·Î ´Ù¸£´Ù´Â Á¡ÀÌ ¾Ë·ÁÁ³´Ù. Çѱ¹À» ºñ·ÔÇÏ¿© ¸¸ÁÖ, ½Ãº£¸®¾Æ µîÁö¿¡¼ À¯ÇàÇÏ´Â ÁúȯÀ¸·Î ¾Ë·ÁÁ³À¸³ª ÇÑź¹ÙÀÌ·¯½ºÀÇ ¹ß°ßÀ» °è±â·Î Ç÷û°Ë»ç°¡ °¡´ÉÇØÁöÀÚ ÇÑź¹ÙÀÌ·¯½º ³»Áö´Â ÀÌ¿Í Ç׿ø±¸Á¶°¡ À¯»çÇÑ ¹ÙÀÌ·¯½º·Î »ý±â´Â °¨¿°ÁõÀÌ ¼¼°è °¢Ã³¿¡ ºÐÆ÷µÇ¾î ÀÖ´Ù´Â °ÍÀÌ ÆÇ¸íµÇ¾ú´Ù. °èÀýÀûÀÎ ¹ß»ýÀº ƯÀÌÇϸç, ±¹³»¿¡¼´Â º½°ú °¡À»¿¡ µÎ ¹øÀÇ À¯ÇàÀÌ ÀÖ´Ù°í ÇÏÁö¸¸ ÃÖ±Ù¿¡´Â °¡À»ÀÇ À¯ÇàÀÌ Å©´Ù. Ư¡ÀûÀÎ À°¾ÈÀû ¼Ò°ßÀº ÄáÆÏ¼ÓÁúÀÇ ÃâÇ÷, ¿À¸¥½É¹æÃâÇ÷, ³úÇϼöü Àü¿±ÀÇ ±«»çÀ̸ç, À̹ۿ¡ Èĺ¹° ¿¬Á¶Á÷ÀÇ ½ÉÇÑ ºÎÁ¾, ü°³»·Î ´©ÃâµÈ ü¾× Àú·ù, À帷ÀÇ »êÀ缺 ÃâÇ÷, µ¹Ã¢ÀÚÀÇ Á¡¸·ÃâÇ÷, ÆóºÎÁ¾ ³»Áö´Â ÆóÃâÇ÷ µîÀÌ´Ù. Á¶Á÷¼Ò°ßÀÇ Æ¯Â¡Àº ¿©·¯ Àå±âÀÇ ÃâÇ÷°ú ÄáÆÏ¼ÓÁú, ³úÇϼöü, ºÎ½Å µî¿¡ »ý±â´Â ÃÊÁ¡¼º ÀÀ°í¼º ±«»ç¿Í °¢ Àå±âÀÇ ±¤¹ü¼º ´ÜÇÙ¼¼Æ÷ ħÀ±À̸ç, ¼¼Á¤¸ÆÀÌ È®ÀåµÇ°í ¿ïÇ÷ÀÌ »ý±â°í Ç÷Àå°ú ÀûÇ÷±¸°¡ Ç÷°ü¿Ü·Î ´©ÃâµÇ°í ºÎÀ§¿¡ µû¶ó¼´Â ÃÊÁ¡¼º ¸ð¼¼Ç÷°ü ÆÄ¿ÀÌ ³ªÅ¸³ª ÀÖ´Ù. |
||
| ¿µ¹® | relapsing fever | ÇÑ±Û | Àç±Í¿ |
|---|---|---|---|
| ¼³¸í | Borrelia ¼ÓÀÇ ½ºÇÇ·ÎÇìŸ °¨¿°¿¡ ÀÇÇØ¼ »ý±ä´Ù. ÀÌ Áøµå±â¿¡ ÀÇÇØ ¸Å°³µÇ°í ¾ÆÇÁ¸®Ä«, ¾Æ½Ã¾Æ, ¹Ì±¹, À¯·´ µî, ¼¼°è °¢Áö¿¡¼ º¼ ¼ö ÀÖ´Ù. Àẹ±â´Â 3~10ÀÏ¿¡ ¿ÀÇÑ, ÀüÀ², µÎÅë, ±¸¿ª µîÀ» ¼ö¹ÝÇÏ´Â ¹ß¿·Î ¹ß»ýÇÑ´Ù. ¹ß¿Àº Á¾Á¾ 40¡É ÀÌ»ó¿¡ ´ÞÇϰí 4~5ÀÏ¿¡ ÀÚ¿¬È÷ ÇØ¿µÈ´Ù. ¾à 1ÁÖÀÏÀÇ ¹«¿±â µÚ, ´Ù½Ã ¶È°°Àº Áõ»óÀ» µÇÇ®ÀÌÇÑ´Ù. ÀÌ¿Í °°Àº ¹ßÀÛÀ» ¼³Ê ¹ø µÇÇ®ÀÌÇÑ´Ù. Ç÷¾×À¸·ÎºÎÅÍÀÇ Borrelia °ËÃâ·Î Áø´ÜÀÌ È®Á¤µÈ´Ù. Åë»ó Ç÷¾×µµ¸» Ç¥º»À» °¨ÀÚ¿°»öÇØ¼ °ËÃâÇÑ´Ù. Ä¡·á¿¡´Â Æä´Ï½Ç¸°, Åׯ®¶ó»çÀÌŬ¸°, Ŭ·Î¶÷Æä´ÏÄÝÀÌ È¿°úÀûÀÌ´Ù. |
||
| YFMD | yellow fever membrane disease |
|---|---|
| RF | 1) Renal Failure 2) Rheumatic Fever ? Rheumatic Fever  ... |
| HF | Hageman factor; haplotype frequency; hard filled [capsule]; hay fever; head of fetus; head forward; ... |
| Q fever | query fever |
| SF | Sabin-Feldman [test]; safety factor; salt-free; scarlet fever; screen film; seminal fluid; serosal f... |
| vaccination, hib | This vaccine is to prevent disease caused by the haemophilus influenzae type b (hib) bacteria. The h. Influenzae (h. Flu) bacteria can cause a range of serious diseases including meningitis with potential brain damage and epiglottitis with airway obstruction poisoning. The hib vaccine is usually given at 2, 4 and 6 months of age. A final booster is given at 12-15 months of age. Hib vaccine rarely causes severe reactions. (12 Dec 1998) |
|---|---|
| vaccination, infectious hepatitis | See Vaccination, hepatitis a. (12 Dec 1998) |
| vaccination, measles | See Vaccination, MMR. Vaccination, mmr: the standard vaccine given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination hould be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination. (12 Dec 1998) |
| vaccination, mumps | See Vaccination, MMR. Vaccination, pneumococcal pneumonia: this vaccine, which prevents one of the most common and severe forms of pneumonia, is usually given only once in a lifetime, usually after the age of 55, to someone with ongoing lung problems (such as chronic obstructive pulmonary disease (copd) or asthma) or other chronic diseases (including those involving the heart and kidneys). This vaccination would rarely be given to children. (12 Dec 1998) |
| vaccination, polio | The vaccines available for vaccination against polio are opv (oral polio vaccine) and ipv (inactivated polio vaccine). Opv is still the preferred vaccine for most children. As its name suggests, it is given by mouth. Ipv, or inactivated polio vaccine is given as a shot in the arm or leg. Infants and children should be given four doses of opv. The doses are given at 2 months, 4 months, 6-18 months and 4-6 years of age. Persons allergic to eggs or the drugs neomycin or streptomycin should receive opv, not the injectable ipv. Conversely, ipv should be given if the vaccine recipient is on long-term steroid (cortisone) therapy, has cancer, or is on chemotherapy or if a household member has aids or there is an unimmunised adult in the house. (12 Dec 1998) |
| vaccination, rubella | See Vaccination, MMR. (12 Dec 1998) |
| vaccination, varicella zoster | See Vaccineation, chickenpox. (12 Dec 1998) |
| varicella vaccination | See Vaccination, chickenpox. (12 Dec 1998) |
| polio vaccination | <virology> The vaccines available for vaccination against polio are opv (oral polio vaccine) and ipv (inactivated polio vaccine). Opv is still the preferred vaccine for most children. As its name suggests, it is given by mouth. Ipv, or inactivated polio vaccine is given as a shot in the arm or leg. Infants and children should be given four doses of opv. The doses are given at 2 months, 4 months, 6-18 months and 4-6 years of age. Persons allergic to eggs or the drugs neomycin or streptomycin should receive opv, not the injectable ipv. Conversely, ipv should be given if the vaccine recipient is on long-term steroid (cortisone) therapy, has cancer, or is on chemotherapy or if a household member has aids or there is an unimmunised adult in the house. (21 Jun 1999) |
| primary vaccination | <virology> First or principal vaccination with the introduction of a vaccine into the body for the purpose of inducing immunity. (18 Nov 1997) |
| DPT vaccination | <immunology> A vaccination administered to infants for protection against diphtheria, pertussis (whooping cough) and tetanus. Vaccinations are typically administered at 2, 4, 6 and 15 months. A final vaccination is now recommended at 4-6 years of age. (27 Sep 1997) |
| acridine yellow | A faintly yellow solution with strong bluish-violet fluorescence; used as a topical antiseptic and as a fluorescent stain in histology. Synonym: 5-aminoacridine hydrochloride, 9-aminoacridine hydrochloride. (05 Mar 2000) |
| acute yellow atrophy of the liver | A lesion in which there is extensive and rapid death of parenchymal cells of the liver, sometimes with fatty degeneration of the size of the organ; the necrosis may result from fulminant viral infection or chemical poisoning; associated with jaundice. Synonym: acute parenchymatous hepatitis, Rokitansky's disease. (05 Mar 2000) |
| brilliant yellow | An indicator dye that changes from yellow to orange or red at pH 6.4 to 8.0. (05 Mar 2000) |
| butter yellow | C6H5N:NC6H4N(CH3)2;a fat-soluble yellow dye (MW 225) that has hepatic carcinogenic action in experimental animals; used as an indicator of pH (red, at pH 2.9, yellow at pH 4.0). Synonym: dimethylaminoazobenzene, methyl yellow. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|